Morpholino

MO1-mios

ID

ZDB-MRPHLNO-210907-4

Name

MO1-mios

Previous Names

None

Target

mios (1)

Sequence

5' - GGCAGGACAGTGGCTTGTTCAGTGC - 3'

Disclaimer

Although ZFIN verifies reagent sequence data, we recommend that you conduct independent sequence analysis before ordering any reagent.

Note

Translation-blocking MO.

Genome Resources

None

Target Location

Genomic Features

No data available

Expression

Gene expression in Wild Types + MO1-mios

Expressed Gene	Anatomy	Figures
atp2a2a	whole organism	Fig. S3 from Kuo et al., 2021
cacna1g	whole organism	Fig. S3 from Kuo et al., 2021
cacna1ha	whole organism	Fig. S3 from Kuo et al., 2021
cacna1hb	whole organism	Fig. S3 from Kuo et al., 2021
cacna1ia	whole organism	Fig. S3 from Kuo et al., 2021
cacna1ib	whole organism	Fig. S3 from Kuo et al., 2021
dab2	posterior cardinal vein	Fig. S1 from Lin et al., 2023
efnb2a	caudal artery dorsal aorta	Fig. S1 from Lin et al., 2023
hcn4	whole organism	Fig. S3 from Kuo et al., 2021

Phenotype

Phenotype resulting from MO1-mios

Phenotype	Fish	Figures
blood circulation disrupted, abnormal	sd2Tg; y1Tg + MO1-mios	Fig. 1 from Lin et al., 2023 Fig. 2 from Kuo et al., 2021
eye decreased size, abnormal	TL + MO1-mios	Fig. 2 from Kuo et al., 2021
head decreased size, abnormal	TL + MO1-mios	Fig. 2 from Kuo et al., 2021
heart decreased functionality, abnormal	TL + MO1-mios	Fig. 2 from Kuo et al., 2021
heart contraction decreased rate, abnormal	TL + MO1-mios	Fig. 2 from Kuo et al., 2021
pericardium edematous, abnormal	TL + MO1-mios	Fig. 2 from Kuo et al., 2021
posterior cardinal vein dab2 expression decreased amount, abnormal	sd2Tg; y1Tg + MO1-mios	Fig. S1 from Lin et al., 2023
posterior cardinal vein hypoplastic, abnormal	sd2Tg; y1Tg + MO1-mios	Fig. 1 from Lin et al., 2023
venous blood vessel development process quality, abnormal	hu5333Tg; y1Tg + MO1-mios	Fig. S1 from Lin et al., 2023
whole organism cacna1ha expression decreased amount, abnormal	TL + MO1-mios	Fig. S3 from Kuo et al., 2021
whole organism cacna1hb expression decreased amount, abnormal	TL + MO1-mios	Fig. S3 from Kuo et al., 2021
whole organism cacna1g expression decreased amount, abnormal	TL + MO1-mios	Fig. S3 from Kuo et al., 2021
whole organism cacna1ia expression decreased amount, abnormal	TL + MO1-mios	Fig. S3 from Kuo et al., 2021
whole organism cacna1ib expression decreased amount, abnormal	TL + MO1-mios	Fig. S3 from Kuo et al., 2021
whole organism atp2a2a expression decreased amount, abnormal	TL + MO1-mios	Fig. S3 from Kuo et al., 2021
whole organism hcn4 expression decreased amount, abnormal	TL + MO1-mios	Fig. S3 from Kuo et al., 2021

Phenotype of all Fish created by or utilizing MO1-mios

Phenotype	Fish	Conditions	Figures
whole organism hcn4 expression decreased amount, abnormal	TL + MO1-mios	standard conditions	Fig. S3 from Kuo et al., 2021
whole organism atp2a2a expression decreased amount, abnormal	TL + MO1-mios	standard conditions	Fig. S3 from Kuo et al., 2021
whole organism cacna1ia expression decreased amount, abnormal	TL + MO1-mios	standard conditions	Fig. S3 from Kuo et al., 2021
head decreased size, abnormal	TL + MO1-mios	standard conditions	Fig. 2 from Kuo et al., 2021
whole organism cacna1hb expression decreased amount, abnormal	TL + MO1-mios	standard conditions	Fig. S3 from Kuo et al., 2021
eye decreased size, abnormal	TL + MO1-mios	standard conditions	Fig. 2 from Kuo et al., 2021
pericardium edematous, abnormal	TL + MO1-mios	standard conditions	Fig. 2 from Kuo et al., 2021
blood circulation disrupted, abnormal	TL + MO1-mios	standard conditions	Fig. 2 from Kuo et al., 2021
whole organism cacna1ha expression decreased amount, abnormal	TL + MO1-mios	standard conditions	Fig. S3 from Kuo et al., 2021
whole organism cacna1ib expression decreased amount, abnormal	TL + MO1-mios	standard conditions	Fig. S3 from Kuo et al., 2021
whole organism cacna1g expression decreased amount, abnormal	TL + MO1-mios	standard conditions	Fig. S3 from Kuo et al., 2021
heart contraction decreased rate, abnormal	TL + MO1-mios	standard conditions	Fig. 2 from Kuo et al., 2021
heart decreased functionality, abnormal	TL + MO1-mios	standard conditions	Fig. 2 from Kuo et al., 2021
venous blood vessel development process quality, abnormal	hu5333Tg; y1Tg + MO1-mios	standard conditions	Fig. S1 from Lin et al., 2023
posterior cardinal vein hypoplastic, abnormal	sd2Tg; y1Tg + MO1-mios	standard conditions	Fig. 1 from Lin et al., 2023
posterior cardinal vein dab2 expression decreased amount, abnormal	sd2Tg; y1Tg + MO1-mios	standard conditions	Fig. S1 from Lin et al., 2023
blood circulation disrupted, abnormal	sd2Tg; y1Tg + MO1-mios	standard conditions	Fig. 1 from Lin et al., 2023
venous blood vessel development process quality, abnormal	sd2Tg; y1Tg + MO1-mios	standard conditions	Fig. S1 from Lin et al., 2023

Citations